LXEO

Latest SEC Filings & News for LXEO

1 most recent filing and news item mentioning LXEO. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/LXEO/news?limit=20"

Pull LXEO filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 15, 2026Positive

Lexeo Therapeutics finalizes SUNRISE-FA 2 pivotal trial design for LX2006 gene therapy

Lexeo Therapeutics announced finalization of the SUNRISE-FA 2 pivotal trial protocol for LX2006 in Friedreich ataxia, with first patient enrollment expected by end of Q2 2026 and BLA submission targeted for 2028. The open-label study design with 13 treated and 13 untreated contro

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.